Clinical Trial Update: The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study

View source ↗

Summary

This real-world, single-center study assesses first-line treatment combined with immunotherapy for advanced hepatocellular carcinoma and is currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Hepatocellular Carcinoma (HCC), Real World Study | Status: NOT_YET_RECRUITING